Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Qyuns Therapeutics Co., Ltd. Class H ( (HK:2509) ).
Qyuns Therapeutics Co., Ltd., a joint stock company incorporated in China, has designated Mr. Fung Che Wai, Anthony as the lead independent non-executive director to enhance corporate governance. This move aligns with the amended Corporate Governance Code effective from July 2025, aiming to improve board effectiveness and communication between directors and shareholders.
More about Qyuns Therapeutics Co., Ltd. Class H
Average Trading Volume: 371,734
Technical Sentiment Signal: Strong Buy
For a thorough assessment of 2509 stock, go to TipRanks’ Stock Analysis page.